More importantly, we found that beta-elemene treatment significantly decreased cyclin D1, c-Myc, Cox2, MMP2/9 expression, which were attenuated by C3orf21 silencing and enhanced by C3orf21 over-expression in NSCLC cells. The gene discussed is XXYLT1; the disease is non-small cell lung carcinoma.